Profil
Mark T.
Tengler is the founder of Spectrix Therapeutics LLC, which is founded in 2016, where he holds the title of Chief Executive Officer.
He also held the position of Chief Technology Officer at Neos Therapeutics, Inc. from 2014 to 2016.
Prior to that, he worked as Operations Director at PharmaPrint, Inc. Mr. Tengler received his undergraduate degree from Colorado State University.
Postes actifs de Mark Tengler
| Sociétés | Poste | Début |
|---|---|---|
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Directeur Général | 01/01/2016 |
Anciens postes connus de Mark Tengler
| Sociétés | Poste | Fin |
|---|---|---|
| NEOS THERAPEUTICS, INC. | President | - |
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology Develop dietary supplement, functional food and pharmaceutical products from botanical sources | Directeur des opérations | - |
Formation de Mark Tengler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology Develop dietary supplement, functional food and pharmaceutical products from botanical sources | Health Technology |
Colorado State University
Colorado State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
















